We hypothesized that genetic variants in the CYP2B6 gene which encodes for CYP2B6 enzyme may result in variability of the formation of acrolein and contribute to the high rate of HC observed in FA patients. This evidence concerns the gene CYP2B6 and Friedreich ataxia.